Skip to main content
logo
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.600
-0.060 (-1.29%)
Aug 21, 2026, 9:46 AM EDT - Market open

Cytek Biosciences Revenue

Cytek Biosciences had revenue of $48.14M in the quarter ending June 30, 2026, with 5.57% growth. This brings the company's revenue in the last twelve months to $206.71M, up 5.44% year-over-year. In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth.

Revenue (ttm)
$206.71M
Revenue Growth
+5.44%
P/S Ratio
2.93
Revenue / Employee
$303,092
Employees
682
Market Cap
597.92M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025201.49M1.04M0.52%
Dec 31, 2024200.45M7.44M3.85%
Dec 31, 2023193.02M28.98M17.67%
Dec 31, 2022164.04M36.09M28.20%
Dec 31, 2021127.95M35.11M37.82%
Dec 31, 202092.84M34.96M60.39%
Dec 31, 201957.88M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
AdaptHealth3.36B
Varex Imaging865.00M
Tactile Systems Technology350.31M
OrthoPediatrics252.72M
Cerus221.55M
NeuroPace106.99M
Delcath Systems95.42M
BrainsWay60.70M
Revenue Rankings

CTKB News

More News